DOSSIER · 13F-HR · Q2 2026

ACT CAPITAL MANAGEMENT, LLC

$153M in tracked AUM across 62 positions as of Q2 2026.

AC
CIK 0001442273 · last filed Jun 30, 2026
Total AUM
$153M
as of Q2 2026
Holdings
62
+6 QoQ
positions
Whale Score
54
54
tracked
Activity
61
+20 new, −14 sold
changes this Q
AI Analysis · Q2 2026

ACT CAPITAL MANAGEMENT, LLC filed its latest 13F-HR for Q2 2026. 61 position changes this quarter — 20 new, 14 exited, 15 added, 12 trimmed.

Quarter at a glance — Q2 2026

61 material changes this filing.

ADD
TGTXTG THERAPEUTICS INC
+2K sh
+$6M
9.0%
ADD
ABVXABIVAX SA
+26K sh
+$5M
8.4%
NEW
TSLATESLA INC
+11K sh
+$5M
3.0%
TRIM
CELCCELCUITY INC
-30K sh
$-4M
4.2%
NEW
ASTSAST SPACEMOBILE INC
+44K sh
+$4M
2.5%
ADD
ARWRARROWHEAD PHARMACEUTICALS INC
+28K sh
+$4M
5.9%
TRIM
AMZNAMAZON.COM INC
-20K sh
$-4M
2.0%

Top 10 holdings

By portfolio weight as of Q2 2026. Source: SEC EDGAR 13F-HR filings.

#HoldingValueSharesWeight
01
KRYS
KRYSTAL BIOTECH INC
$17M45K10.9%
02
TGTX
TG THERAPEUTICS INC
$14M251K9.0%
03
ABVX
ABIVAX SA
$13M97K8.4%
04
CVX
CHEVRON CORP
$12M75K8.1%
05
XOM
EXXON MOBIL CORP
$11M79K7.0%
06
ARWR
ARROWHEAD PHARMACEUTICALS INC
$9M110K5.9%
07
VKTX
VIKING THERAPEUTICS INC
$8M209K5.3%
08
CELC
CELCUITY INC
$7M62K4.2%
09
NKTR
NEKTAR THERAPEUTICS
$6M89K4.1%
10
TSLA
TESLA INC
$5M11K3.0%

Filing history

2026Q2Jun 30
$153M▲ 20.3%
62 positionsView →
2026Q1Mar 31
$127M▲ 2.9%
56 positionsView →
2025Q4Dec 31
$124M▲ 70.7%
59 positionsView →
2022Q3Sep 30
$72M▲ 1.3%
71 positionsLocked
2022Q2Jun 30
$72M▼ 24.4%
78 positionsLocked
2022Q1Mar 31
$95M▼ 31.7%
85 positionsLocked
2021Q4Dec 31
$138M▼ 28.3%
92 positionsLocked
2021Q3Sep 30
$193M▼ 0.8%
108 positionsLocked
2021Q2Jun 30
$195M—
117 positionsLocked